2020
DOI: 10.1016/j.amjoto.2020.102591
|View full text |Cite
|
Sign up to set email alerts
|

Management of acquired cholesteatoma in patients with craniofacial anomalies: An institutional experience

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

0
5
0

Year Published

2022
2022
2023
2023

Publication Types

Select...
2

Relationship

0
2

Authors

Journals

citations
Cited by 2 publications
(5 citation statements)
references
References 24 publications
0
5
0
Order By: Relevance
“…Different descriptions of procedure success were extracted, with the most common being no revision surgery and intact tympanic membrane. The 4 studies of patients with cholesteatoma considered recurrent cholesteatoma as their procedure success 47–49,51 . Mean follow‐up ranged from 25.0 to 160.8 months for patients with cleft palate repair and 31.3 to 75.0 months for controls.…”
Section: Resultsmentioning
confidence: 99%
See 4 more Smart Citations
“…Different descriptions of procedure success were extracted, with the most common being no revision surgery and intact tympanic membrane. The 4 studies of patients with cholesteatoma considered recurrent cholesteatoma as their procedure success 47–49,51 . Mean follow‐up ranged from 25.0 to 160.8 months for patients with cleft palate repair and 31.3 to 75.0 months for controls.…”
Section: Resultsmentioning
confidence: 99%
“…Patients with both cleft lip and cleft palate repair made up 61.4% of the group with cleft palate repair. Most studies analyzed outcomes after myringoplasty or tympanoplasty, 29,43–46 but some studies included tympanomastoidectomy 47–49 . Four studies excluded patients with cholesteatoma 43,44,46,50 , 4 studies included only patients with cholesteatoma 47–49,51 , and 3 studies included a range of patients with cholesteatoma (5.0%‐36.8%) 28,29,45 .…”
Section: Resultsmentioning
confidence: 99%
See 3 more Smart Citations